2025
$0.43
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$89.5M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$20.5M; SBC=$38.3M; capex=$14.1M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $1,439.3M vs prior $1,285.7M, growth capex=$2.1M, maintenance capex=$12.0M; OE=$18.7M; diluted shares=43.56M; OE/sh=$0.4287. Reconciliation: NI $19.4M + D&A $15.8M + other non-cash $(4.6)M (incl. $7.8M non-cash realized gain on preferred stock exchange removed) - maint capex = $18.7M (matches). Source: accession 0001371285-26-000018 (FY2025 10-K).
2024
$0.07
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$48.3M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$4.5M; SBC=$33.4M; capex=$9.7M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $1,285.7M vs prior $1,108.6M, growth capex=$2.4M, maintenance capex=$7.3M; OE=$3.1M; diluted shares=42.16M; OE/sh=$0.0730. Reconciliation: NI $(9.6)M + D&A $16.5M + other non-cash $3.6M - maint capex = $3.1M (matches). Source: accession 0001371285-26-000018 (FY2025 10-K).
2023
-$1.12
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$18.6M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$16.3M; SBC=$33.2M; capex=$18.3M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $1,108.6M vs prior $905.2M, growth capex=$2.8M, maintenance capex=$15.5M; OE=$(46.4)M; diluted shares=41.44M; OE/sh=$-1.1194. Reconciliation: NI $(44.7)M + D&A $12.5M + other non-cash $1.3M - maint capex = $(46.4)M (matches). Source: accession 0001371285-26-000018 (FY2025 10-K).
2022
-$1.15
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$(8.0)M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$(8.7)M; SBC=$33.4M; capex=$17.1M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $905.2M vs prior $699.0M, growth capex=$2.8M, maintenance capex=$14.3M; OE=$(47.0)M; diluted shares=40.77M; OE/sh=$-1.1525. Reconciliation: NI $(44.7)M + D&A $10.9M + other non-cash $1.1M - maint capex = $(47.0)M (matches). Source: accession 0001371285-23-000047 (FY2022 10-K).
2021
-$0.88
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$7.5M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$4.7M; SBC=$28.2M; capex=$12.4M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $699.0M vs prior $502.0M, growth capex=$2.7M, maintenance capex=$9.7M; OE=$(35.2)M; diluted shares=40.14M; OE/sh=$-0.8762. Reconciliation: NI $(35.5)M + D&A $12.0M + other non-cash $(1.9)M - maint capex = $(35.2)M (matches). Source: accession 0001371285-23-000047 (FY2022 10-K).
2020
-$0.12
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$21.5M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$11.2M; SBC=$8.9M; capex=$7.5M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $502.0M vs prior $383.9M, growth capex=$1.6M, maintenance capex=$5.8M; OE=$(4.5)M; diluted shares=35.86M; OE/sh=$-0.1244. Reconciliation: NI $(5.8)M + D&A $7.1M + other non-cash $0.15M - maint capex = $(4.5)M (matches). Source: accession 0001371285-23-000047 (FY2022 10-K).
2019
-$0.01
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$16.2M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$5.4M; SBC=$6.8M; capex=$5.4M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $383.9M vs prior $304.0M, growth capex=$1.1M, maintenance capex=$4.3M; OE=$(0.36)M; diluted shares=34.65M; OE/sh=$-0.0103. Reconciliation: NI $(1.8)M + D&A $5.6M + other non-cash $0.10M - maint capex = $(0.36)M (matches). Source: accession 0001371285-20-000032 (FY2019 10-K).
2018
$0.00
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$12.7M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$4.6M; SBC=$4.8M; capex=$56.9M; 2018 reported capex $56.9M included the August 2018 purchase of the Seattle headquarters building (one-time real-estate purchase replacing rent); excluded, and underlying capex set at the period capex ratio x revenue = $4.1M. capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $304.0M vs prior $242.7M, growth capex=$0.83M, maintenance capex=$3.3M; OE=$0.04M; diluted shares=31.96M; OE/sh=$0.0013. Reconciliation: NI $(0.93)M + D&A $4.5M + other non-cash $(0.24)M - maint capex = $0.04M (matches). Source: accession 0001371285-20-000032 (FY2019 10-K).
2017
-$0.04
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$9.7M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$4.9M; SBC=$3.4M; capex=$3.1M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $242.7M vs prior $188.2M, growth capex=$0.74M, maintenance capex=$2.4M; OE=$(1.1)M; diluted shares=29.59M; OE/sh=$-0.0365. Reconciliation: NI $(1.5)M + D&A $4.2M + other non-cash $(1.4)M - maint capex = $(1.1)M (matches). Source: accession 0001371285-20-000032 (FY2019 10-K).
2016
-$0.15
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$5.0M; dWC (receivables, prepaids, payables/accruals, reserve for veterinary invoices, deferred revenue; net cash effect)=$5.0M; SBC=$2.9M; capex=$1.9M; capex ratio=1.36% (mean 2016-2025 ex-2018), revenue $188.2M vs prior $147.0M, growth capex=$0.56M, maintenance capex=$1.4M; OE=$(4.3)M; diluted shares=28.53M; OE/sh=$-0.1516. Reconciliation: NI $(6.9)M + D&A $3.8M + other non-cash $0.10M - maint capex = $(4.3)M (matches). Source: accession 0001371285-19-000039 (FY2018 10-K).
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.